Related Experiment Videos
Primary Biliary Cholangitis
Francesca Bolis1, Marco Carbone1
1Department of Medicine and Surgery, Centre for Autoimmune Liver Diseases, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy; Liver Unit, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy.
Primary biliary cholangitis (PBC) is an autoimmune liver disease. Early diagnosis and ursodeoxycholic acid (UDCA) treatment improve prognosis, while symptom management and surveillance are key for long-term patient care.
Area of Science:
- Hepatology
- Autoimmune Diseases
- Gastroenterology
Background:
- Primary biliary cholangitis (PBC) is a chronic, autoimmune cholestatic liver disease.
- It is characterized by persistent cholestasis and progressive liver fibrosis.
- Diagnosis typically involves cholestatic biochemistry and specific antibody positivity.
Purpose of the Study:
- To outline the diagnostic criteria for PBC.
- To discuss current first-line treatment strategies and their prognostic implications.
- To emphasize the importance of symptom management and long-term surveillance in PBC patients.
Main Methods:
- Review of diagnostic markers including cholestatic biochemistry, antimitochondrial antibodies (AMA), and PBC-specific antinuclear antibodies.
- Evaluation of ursodeoxycholic acid (UDCA) as the primary therapeutic agent.
- Discussion of symptom management strategies for pruritus, fatigue, and sicca symptoms.
- Outline of long-term monitoring protocols for treatment response, fibrosis, portal hypertension, bone disease, and hepatocellular carcinoma (HCC).
Main Results:
- Biochemical response to UDCA treatment is a significant predictor of long-term prognosis.
- Effective management of symptoms like pruritus and fatigue is essential for patient quality of life.
- Regular surveillance is necessary to detect complications such as fibrosis, portal hypertension, and HCC.
Conclusions:
- UDCA is the established first-line treatment for PBC, with treatment response guiding prognosis.
- Comprehensive management encompassing symptom control and vigilant surveillance is crucial for patients with PBC.
- Liver transplantation (LT) remains the definitive treatment for advanced or refractory PBC, with UDCA use post-LT recommended to prevent recurrence.
Related Concept Videos
Cholecystitis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction